Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007, 151(2):247-249 | DOI: 10.5507/bp.2007.041

Use of glycogen phosphorylase BB measurement with POCT in the diagnosis of acute coronary syndromes. A comparison with the ELISA method

David Stejskala, Borek Lacnaka, Libor Jedelskya, Leona Stepanovaa, Jitka Proskovaa, Pavlina Solichovaa, Lenka Kadalovaa, Marie Janosovaa, Petra Seitlovaa, Michal Karpisekb, Ludek Spronglc
a Department of Laboratory Medicine and Department of Internal Medicine, Sternberk Hospital, Czech Republic
b Institute of Human Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Veterinary and Pharmaceutical University Brno, Czech Republic
c Central Laboratory, Sumperk Hospital, Czech Republic

Background: Glycogen Phosphorylase BB (GPBB) is considered an early and specific marker of myocardial necrosis and ischemia. A POCT kit GPBB for diagnostic use has recently been approved.

Aim: an evaluation of the correspondence of qualitative POCT GBPP measurements with ELISA test results. Material and methodology: 20 individuals with non-ST elevation myocardial infarction (non-STEMI) and 20 probands without acute coronary syndrome (ACS) were tested. GPBB (POCT, ELISA) in venous plasma (lithium-heparin) was assayed in all probands.

Results: individuals with non-STEMI had significantly higher GPBB ELISA values (32.3 vs. 6.1 μg/l; p < 0.01). GPBB sensitivity and specificity for non-STEMI presence 6 hours after chest pain generation were 100 %. No proband was classified in a different subgroup with POCT of GPBB (positive/negative). GPBB POCT correlate with a non- STEMI diagnosis (χ2 36.1; p <0.01).

Conclusion: GPBB POCT measurement is comparable with ELISA test results. GPBB analysis could expand the diagnostic palette in the first hours after the onset of acute coronary syndrome.

Keywords: Acute coronary syndrome, Myocardial ischemia, Non-STEMI, Coronary by-pass, Laboratory markers of myocardial ischemia, CAD, GPBB, POCT, ELISA

Received: August 21, 2007; Accepted: November 10, 2007; Published: December 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Stejskal, D., Lacnak, B., Jedelsky, L., Stepanova, L., Proskova, J., Solichova, P., ... Sprongl, L. (2007). Use of glycogen phosphorylase BB measurement with POCT in the diagnosis of acute coronary syndromes. A comparison with the ELISA method. Biomedical papers151(2), 247-249. doi: 10.5507/bp.2007.041
Download citation

References

  1. Apple FS, Wu AHB, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, Jaff e AS. Future Biomarkers for Detection of Ischemia and Risk Stratifi cation in Acute Coronary Syndrome. Clin. Chem 2005; 51:810824. Go to original source... Go to PubMed...
  2. Mair J, Puschendorf B, Amidy J, Lechleitner P, Dienstl F, Noll F, Krause EG, Rabitzsch G. Early release of glycogen phosphorylase in patients with unstable angina and transient ST-T alterations. British Heart Journal 1994; 72:125127. Go to original source... Go to PubMed...
  3. Rabitzsch G, Mair J, Lechleitner P, Noll F, Hofmann U, Krause EG, Dienstl F, Puschendorf B. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin. Chem 1995; 41:966978. Go to original source...
  4. Mair P, Mair J, Krause EG, Balogh D, Puschendorf B, Rabitzsch G. Glycogen phosphorylase isoenzyme BB mass release after coronary artery bypass grafting. Eur J Clin Chem Clin Biochem 1994; 32:543547. Go to original source...
  5. Peetz D, Post F, Schinzel H, Schweigert R, Schollmayer C, Steinbach K, Dati F, Noll F, Lackner KJ. Glycogen phosphorylase BB in acute coronary syndromes. Clin Chem Lab Med. 2005; 43:13511358. Go to original source... Go to PubMed...
  6. Hofmann U, Rabitzsch G, Loster K, Handschack W, Noll F, Krause EG. Immunenzymometric assay for the heart specifi c glycogen phosphorylase BB in human serum using monoclonal antibodies. Biomed Biochim Acta 1989; 48:132136.
  7. Diagenics [online]. Dostupne z WWW http://www.diagenics.de
  8. Kemp M, Donova J, Higham H, Hooper J. Biochemical markers of myocardial injury. British Journal of Anaesthesia 2004; 93:63 73. Go to original source... Go to PubMed...
  9. Wu AHB, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases. Clin Chem 1999; 45:1104 1121. Go to original source...
  10. Mair J. Glycogen phosphorylase isoenzyme BB to diagnose ischaemic myocardial damage. Clin Chim Acta 1998; 272:7986. Go to original source... Go to PubMed...
  11. Proskova J, Stejskal D, Lacnak B, Vaclavik J, Solichova P, Karpisek M, Kaminek M. Glycogenphosphorylase BB in the early diagnosis of ACS. Clin Chem Lab Med 2007; S1:W288.